PoC Molecular Diagnostics Market: By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based and Microarray-based), By Test Location (OTC and POC), By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology and Other Applications), By End User (Decentralized Labs, Hospitals, Home-care, Assisted Living Healthcare Facilities and Other users) and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

PoC Molecular Diagnostics Market size was valued at USD 2.50 billion in 2021 and is expected to reach USD 3.9 billion by 2028, at a CAGR of 11.69% during the forecast period 2022-2028. Rising focus on decentralized diagnostics, increasing worldwide prevalence of infectious diseases, improved need for accurate and faster testing methods, growing awareness regarding benefits of early disease diagnosis and awareness amongst people will increase demand for point of care molecular diagnostics and growing demand for CLIA-waived molecular POC tests are some key factors fostering the market growth. However, factors such as Inadequate Reimbursements and strict government regulations are hindering the market growth. This report studies global PoC molecular diagnostics market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Global Poc Molecular Diagnostics Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

PoC Molecular Diagnostics Market Dynamics

Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system. Many tests have received clinical laboratory improvement amendments (CLIA) waivers that enable POC use. CLIA-waived tests are typically simple and have a low risk for an incorrect result. With CLIA waiver, these tests can be used in a wide range of settings including pharmacy-based clinics, urgent care centers and hospitals, increasing access to testing and streamlining care. Another feature of many POC molecular flu tests is room temperature storage of test components, creating a more versatile lab footprint and allowing testing to be performed in a variety of locations.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Poc Molecular Diagnostics Market Segmentation

  • PCR-based
  • Genetic Sequencing-based
  • Hybridization-based
  • Microarray-based
Test Location
  • OTC
  • POC
By End User
  • Decentralized Labs
  • Hospitals
  • Home-care
  • Assisted Living Healthcare Facilities
  • Other users

Frequently Asked Questions

The poc molecular diagnostics market is projected to expand at a CAGR of 11.69% during the forecast period

Abbott Laboratories, Danaher Corporation, Biomérieux Sa, Roche Diagnostics, Quidel, Meridian Bioscience, Mesa Biotech, Genepoc, DxNA, Atlas Genetics, Spartan Bioscience

North America is the fastest-growing region for poc molecular diagnostics market

  • Abbott Laboratories
  • Danaher Corporation
  • Biomérieux Sa
  • Roche Diagnostics
  • Quidel
  • Meridian Bioscience
  • Mesa Biotech
  • Genepoc
  • DxNA
  • Atlas Genetics
  • Spartan Bioscience
  • Biocartis